Not a great time to be in SLA. Probably should have sold last week. Down another 20% today.Next week is another story. It will probably double when the market bounces. And should reach $5 by year-end.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress